
Sharp Corp
Works across the world to create unique commercial and clinical packaging solutions for the pharmaceutical and biotechnology industry.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
* | N/A | $713m | Debt |
Total Funding | 000k |
Sharp is a global leader in clinical supply chain services and contract pharmaceutical services. The company specializes in providing comprehensive solutions for pharmaceutical manufacturing, packaging, and distribution. Sharp serves a wide range of clients in the pharmaceutical and biotech industries, including those involved in clinical trials and commercial drug production. The company operates in the global market, offering services that range from sterile fill-finish to gene therapy packaging and distribution.
Sharp's business model is centered around providing high-quality, integrated services that help clients reduce the time, cost, and complexity of bringing new drugs to market. The company makes money through contract manufacturing and packaging services, offering specialized solutions such as design and serialization for blisters, bottles, specialty injectables, and more. Sharp also invests in new technologies and facilities to stay ahead in the competitive pharmaceutical services market.
Keywords: clinical supply chain, pharmaceutical manufacturing, contract packaging, gene therapy, sterile fill-finish, serialization, biotech, clinical trials, global market, drug commercialization.
Tech stack
Investments by Sharp Corp
Edit